How can you really be sure that your heart is in good condition?
High Cholesterol and Plaque Tests are not the most effective indicators of Cardiac Health.
DID YOU KNOW...
50% of Heart Attack victims have normal cholesterol.
That’s because multiple factors in addition to cholesterol are required to determine the underlying cause of Heart Attack. Traditional blood tests only test a few indications of cardiac problems. Wellness by Nature Medical Contributor, Douglas Harrington MD has developed an amazing new way to detect if you're at risk of a heart attack within the next 5 years.
The PULS Cardiac Test Measures the Leading Cause of Heart Attacks
There are different blood markers that have been shown to accurately assess cardiac health so that you can change your lifestyle before a life-changing event such as a massive heart attack.
The PULS Test can detect a heart attack within the next 5 years. See how the Spokane Indian Nation uses PULS Test for better wellness as well as 1900+ other medical practices. Learn more about this at pulstest.com.
ABOUT THE AUTHOR
Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of Dr. Jack Copeland’s, first heart transplant team in Arizona in 1979, and co-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings.
Dr. Harrington has developed patents for an automated method for image analysis of residual cancer protein, a patent covering catalytic heavy metal extraction, and a patent pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.